Quanterix (NASDAQ:QTRX) PT Lowered to $60.00 at JPMorgan Cha

Quanterix (NASDAQ:QTRX – Get Rating) had its price target trimmed by JPMorgan Chase & Co. from $85.00 to $60.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. Other equities research analysts also recently issued reports about the company. Zacks Investment Research upgraded […]

Related Keywords

Arizona , United States , Texas , Thomson Reuter , Davidc Duffy , Custom Assay Development , Securities Exchange Commission , Zacks Investment Research , Simoa Accelerator Laboratory , Deutsche Bank , Nasdaq , Jpmorgan Chase Co , Quanterix Corp , Goldman Sachs Group , Group Plc , Quanterix Company Profile Get Rating , Get Rating , Investment Research , Exchange Commission , State Retirement System , General Group Plc , Teacher Retirement System , Retirement System , Company Profile , Simoa Assay Kits , Analysis System , Custom Assay , Quanterix , Nasdaq Qtrx , Qtrx , Medical , Lower Price Target ,